A primary hepatic angiosarcoma mimicking intrahepatic cholangiocarcinoma on conventional ultrasound and contrast-enhanced ultrasound: A case report and review of literatures
Restricted accessCase reportFirst published online May 5, 2017
A primary hepatic angiosarcoma mimicking intrahepatic cholangiocarcinoma on conventional ultrasound and contrast-enhanced ultrasound: A case report and review of literatures
Primary hepatic angiosarcoma (PHA) is a rare malignancy with a badly poor prognosis. The extremely low morbidity and untypical clinical manifestations conduce to a missed diagnosis. The present study reported a case of an adult male patient who was pathologically confirmed to be PHA, which mimicked intrahepatic cholangiocarcinoma on conventional ultrasound and contrast-enhanced ultrasound. Findings on various imaging examinations were carefully evaluated and the associated literatures were also reviewed.
AlrengaD.P., Primary angiosarcoma of the liver. Review article, Int Surg60(4) (1975), 198–203.
2.
Bioulac-SageP., LaumonierH., LaurentC., et al., Benign and malignant vascular tumors of the liver in adults, Semin Liver Dis28(3) (2008), 302–314.
3.
CassinottoC., RullierA., HocqueletA., et al., Hepatic angiosarcoma: A suggestive pattern of enhancement on dynamic MR imaging, Diagn Interv Imaging96(3) (2015), 293–295.
4.
ChenG., LiJ., WanR., et al., Primary hepatic angiosarcoma in a 64-year-old man: A case report, Oncol Lett11(4) (2016), 2445–2448.
5.
ChienC.Y., HwangC.C., YehC.N., et al., Liver angiosarcoma, a rare liver malignancy, presented with intraabdominal bleeding due to rupture–a case report, World J Surg Oncol10 (2012), 23.
6.
Cioffi-PrettiJ.L., KalofA.N., EbertG., et al., Hepatic angiosarcoma five years following spontaneous intraperitoneal bleed of a hepatic mass, Rare Tumors1 (2009), e33.
7.
ClaudonM., DietrichC.F., ChoiB.I., et al., Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver –update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS, Ultrasound Med Biol39(2) (2013), 187–210.
8.
GeramizadehB., SafariA., BahadorA., et al., Hepatic angiosarcoma of childhood: A case report and review of literature, J Pediatr Surg46(1) (2011), e9–e11.
9.
GreisC., Technical aspects of contrast-enhanced ultrasound (CEUS) examinations: Tips and tricks, Clin Hemorheol Microcirc58(1) (2014), 89–95.
10.
GuoL.H. and XuH.X., Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: Controversy over the ASSLD guideline, Biomed Res Int2015 (2015), 349172.
11.
HacklC., SchachererD., AndersM., et al., Improved Detection of preclinical Colorectal Liver Metastases by High Resolution Ultrasound including Molecular Ultrasound Imaging using the targeted Contrast Agent BR55, Ultraschall Med37(3) (2016), 290–296.
12.
HarveyC.J., BlomleyM.J.K., EckersleyR.J., et al., Pulse-inversion mode imaging of liver specific microbubbles: Improved detection of subcentimetre metastases, 355(9206) (2000), 807–808.
13.
ItaiY. and TeraokaT., Angiosarcoma of the liver mimicking cavernous hemangioma on dynamic CT, J Comput Assist tomo13(5) (1989), 910–912.
14.
JungE.M., RossC.J., RennertJ., et al., Characterization of microvascularization of liver tumor lesions with high resolution linear ultrasound and contrast enhanced ultrasound (CEUS) during surgery: First results, Clin Hemorheol Microcirc46(2-3) (2010), 89–99.
15.
KojiroM., NakashimaT., ItoY., et al., Thorium dioxide-related angiosarcoma of the liver. Pathomorphologic study of 29 autopsy cases, Arch Pathol Lab Med109(9) (1985), 853–857.
16.
KoyamaT., FletcherJ.G., JohnsonC.D., et al., Primary hepatic angiosarcoma: Findings at CT and MR imaging, Radiology222(3) (2002), 667–673.
17.
LockerG.Y., DoroshowJ.H., ZwellingL.A., et al., The clinical features of hepatic angiosarcoma: A report of four cases and a review of the English literature, Medicine58(1) (1979), 48–64.
18.
SchachererD., GirlichC., WiestR., et al., Semiquantitative characterization of hepatocellular carcinoma (HCC)–perfusion with contrast-enhanced ultrasound and perfusion analysis, Clin Hemorheol Microcirc44(2) (2010), 97–105.
19.
TrojanJ., HammerstinglR., EngelsK., et al., Contrast-enhanced ultrasound in the diagnosis of malignant mesenchymal liver tumors, J Clin Ultrasound38(5) (2010), 227–231.
20.
WangL., LvK., ChangX.Y., et al., Contrast-enhanced ultrasound study of primary hepatic angiosarcoma: A pitfall of non-enhancement, Eur J Radiol81(9) (2012), 2054–2059.
21.
WangZ.B., YuanJ., ChenW., et al., Transcription factor ERG is a specific and sensitive diagnostic marker for hepatic angiosarcoma, World J Gastroenterol20(13) (2014), 3672–3679.
22.
XiaY., JiangY.X., DaiQ., et al., Contrast-enhanced ultrasound of hepatocellular carcinoma: Correlation of washout time and angiogenesis, Clin Hemorheol Microcirc48(4) (2011), 265–273.
23.
XuH.X., LiuG.J., LuM.D., et al., Characterization of focal liver lesions using contrast-enhanced sonography with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agent, J Clin Ultrasound34(6) (2006), 261–272.
24.
XuH.X., WangY., LuM.D., et al., Percutaneous ultrasound-guided thermal ablation for intrahepatic cholangiocarcinoma, Brit J Radiol85(1016) (2012), 1078–1084.
25.
YamanakaT., ShirakiK., ItoT., et al., Hepatic angiosarcoma mimicking cavernous hemangioma on angiography, Hepato-gastroenterol49(47) (2002), 1425–1427.
26.
ZafraniE.S., Update on vascular tumours of the liver, 8(1) (1989), 125–130.
27.
ZhuY.P., ChenY.M., MatroE., et al., Primary hepatic angiosarcoma: A report of two cases and literature review, World J Gastroenterol21(19) (2015), 6088–6096.
